Literature DB >> 11706979

Helicobacter pylori-induced reduction of acute levodopa absorption in Parkinson's disease patients.

M Pierantozzi, A Pietroiusti, A Galante, G Sancesario, G Lunardi, E Fedele, P Giacomini, P Stanzione.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11706979     DOI： 10.1002/ana.1267

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  12 in total

1.  Levodopa availability improves with progression of Parkinson's disease.

Authors:  Dirk Woitalla; Oliver Goetze; Jeong I Kim; Alice B Nikodem; Wolfgang E Schmidt; Horst Przuntek; Thomas Müller
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

Review 2.  Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence.

Authors:  Guy-D Eslick
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

3.  Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease.

Authors:  André Charlett; R John Dobbs; Sylvia M Dobbs; Clive Weller; Mohammad A A Ibrahim; Tracy Dew; Roy Sherwood; Norman L Oxlade; J Malcolm Plant; James Bowthorpe; Andrew J Lawson; Alan Curry; Dale W Peterson; Ingvar T Bjarnason
Journal:  Gut Pathog       Date:  2009-11-26       Impact factor: 4.181

4.  Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease.

Authors:  Hasriza Hashim; Shahrul Azmin; Hamizah Razlan; Nafisah Wan Yahya; Hui Jan Tan; M Rizal Abdul Manaf; Norlinah Mohamed Ibrahim
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

Review 5.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

Review 6.  The gut microbiome: an orchestrator of xenobiotic metabolism.

Authors:  Stephanie L Collins; Andrew D Patterson
Journal:  Acta Pharm Sin B       Date:  2019-12-10       Impact factor: 11.413

7.  High prevalence of gastroesophageal reflux disease in Parkinson's disease: a questionnaire-based study.

Authors:  Tetsuya Maeda; Ken Nagata; Yuichi Satoh; Takashi Yamazaki; Daiki Takano
Journal:  Parkinsons Dis       Date:  2013-02-11

Review 8.  The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.

Authors:  Elaine F Enright; Cormac G M Gahan; Susan A Joyce; Brendan T Griffin
Journal:  Yale J Biol Med       Date:  2016-09-30

Review 9.  Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease.

Authors:  David J McGee; Xiao-Hong Lu; Elizabeth A Disbrow
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 10.  Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice.

Authors:  Chaonan Sun; Ling Chen; Zhu Shen
Journal:  Saudi Pharm J       Date:  2019-10-24       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.